Skip to main content
logo
Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.910
-0.030 (-1.55%)
At close: Jul 31, 2026, 4:00 PM EDT
1.930
+0.020 (1.05%)
Pre-market: Aug 3, 2026, 5:30 AM EDT

Compass Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-68.17-66.49-49.38-42.49-39.23-82.18
Depreciation & Amortization
0.150.280.590.70.780.57
Stock-Based Compensation
10.938.378.566.125.334.03
Other Adjustments
-0.58-0.48-0.49-2.040.2551.68
Changes in Accounts Payable
-0.67-0.66-1.840.712.52-0.19
Changes in Accrued Expenses
-5.215.13.77-9.182.927.02
Changes in Other Operating Activities
10.364.75-6.075.56-6.69-0.58
Operating Cash Flow
-53.2-49.14-44.86-40.62-34.13-19.67
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.09-0.03-0.04-0.03-0.21-1.57
Sale of Property, Plant & Equipment
----0.180.12
Purchases of Investments
-214.54-194.56-88.16-155.42-200.12-
Proceeds from Sale of Investments
148.16101.28134.97182.4148.96-
Other Investing Activities
------0.32
Investing Cash Flow
-66.47-93.3146.7726.97-151.2-1.77

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
------9.38
Net Long-Term Debt Issued (Repaid)
------9.38
Issuance of Common Stock
-139.2718.113.1976.25128.27
Repurchase of Common Stock
-0.7-1.03-0.23-0.16--
Net Common Stock Issued (Repurchased)
-0.7138.2517.883.0376.25128.27
Other Financing Activities
--8.64-0.54-0.09-0.5-0.28
Financing Cash Flow
133.79129.6117.342.9475.76118.61

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
14.12-12.8419.26-10.72-109.5797.18

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-53.29-49.17-44.9-40.65-34.34-21.23
Free Cash Flow Growth
------
FCF Margin
---5282.24%---
Free Cash Flow Per Share
-0.31-0.31-0.33-0.32-0.33-0.34
Levered Free Cash Flow
-63.64-57.06-52.97-44.73-39.92-86.31
Unlevered Free Cash Flow
-70.64-136.25-117.7-52.6-42.35-76.64
SEC Filings: 10-K · 10-Q